Tapewire

NYSE · USD

G

Genpact LTD

Export transactions ↓
Tapewire entity
3760
SEC CIK
0001398659
Parsed reports
457

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202602
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202606
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 04, 2023 Filed May 8, 2023 20:13 UTC GrantCommon Shares 4,916 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-023501 · form4.xml · nonDerivative · entry 1

Morken CeCelia · CIK 0001367198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,228

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:12 UTC
Verdi Mark ADirector
GrantCommon Shares 4,916 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-023498 · form4.xml · nonDerivative · entry 1

Verdi Mark A · CIK 0001560520 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,473

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:12 UTC GrantCommon Shares 4,916 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-023497 · form4.xml · nonDerivative · entry 1

Cartwright Stacey · CIK 0001793588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,806

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:12 UTC GrantCommon Shares 4,916 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-023494 · form4.xml · nonDerivative · entry 1

Lindstrom Carol · CIK 0001677400 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,113

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:12 UTC GrantCommon Shares 4,916 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-023493 · form4.xml · nonDerivative · entry 1

Conigliaro Laura · CIK 0001528935 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,684

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024.

Read SEC document
May 03, 2023 Filed May 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-023206 · form4.xml · derivative · entry 7

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
May 03, 2023 Filed May 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 50,000 $43.39 $2,169,285.00
Disclosure

SEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 2

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.052 to $43.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 03, 2023 Filed May 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
May 02, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · derivative · entry 8

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
May 02, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 3,684 $44.55 $164,133.62
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 5

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F4 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.46 to $44.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 02, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 46,316 $43.79 $2,028,335.11
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 4

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 809,193

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.45 to $44.44. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 02, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 3

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
May 02, 2023 Filed May 4, 2023 16:11 UTC
Mehta PiyushSenior Vice President and CHRO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 32,500 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-022950 · form4.xml · derivative · entry 4

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 32,500 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
May 02, 2023 Filed May 4, 2023 16:11 UTC
Mehta PiyushSenior Vice President and CHRO
SaleCommon Shares 2,571 $44.54 $114,524.42
Disclosure

SEC source: 0001140361-23-022950 · form4.xml · nonDerivative · entry 3

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 209,040

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022.

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.44 to $44.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 02, 2023 Filed May 4, 2023 16:11 UTC
Mehta PiyushSenior Vice President and CHRO
SaleCommon Shares 29,929 $43.79 $1,310,543.02
Disclosure

SEC source: 0001140361-23-022950 · form4.xml · nonDerivative · entry 2

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,611

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022.

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.45 to $44.36. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 02, 2023 Filed May 4, 2023 16:11 UTC
Mehta PiyushSenior Vice President and CHRO
Exercise / conversionCommon Shares 32,500 $19.35 $628,875.00
Disclosure

SEC source: 0001140361-23-022950 · form4.xml · nonDerivative · entry 1

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 241,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022.

Read SEC document
May 01, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · derivative · entry 7

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
May 01, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 50,000 $44.49 $2,224,315.00
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 2

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.29 to $44.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 01, 2023 Filed May 3, 2023 20:11 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
April 06, 2023 Filed Apr 7, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-017332 · form4.xml · derivative · entry 7

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
April 06, 2023 Filed Apr 7, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 50,000 $44.87 $2,243,530.00
Disclosure

SEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 4

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.732 to $45.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 06, 2023 Filed Apr 7, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 3

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
April 05, 2023 Filed Apr 7, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-017332 · form4.xml · derivative · entry 6

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
April 05, 2023 Filed Apr 7, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 50,000 $45.18 $2,258,850.00
Disclosure

SEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 2

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.90 to $45.69. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 05, 2023 Filed Apr 7, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-016709 · form4.xml · derivative · entry 7

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 50,000 $45.46 $2,273,095.00
Disclosure

SEC source: 0001140361-23-016709 · form4.xml · nonDerivative · entry 4

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.24 to $46.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-016709 · form4.xml · nonDerivative · entry 3

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001140361-23-016709 · form4.xml · derivative · entry 6

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Shares · 50,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 50,000 $45.93 $2,296,615.00
Disclosure

SEC source: 0001140361-23-016709 · form4.xml · nonDerivative · entry 2

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 805,509

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.73 to $46.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 50,000 $19.35 $967,500.00
Disclosure

SEC source: 0001140361-23-016709 · form4.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 855,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 16:08 UTC
Stein Kathryn VanpeltSenior Vice President
GrantCommon Shares 9,878 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005249 · doc1.xml · nonDerivative · entry 2

Stein Kathryn Vanpelt · CIK 0001806002 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,848

F3 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 16:08 UTC
Stein Kathryn VanpeltSenior Vice President
GrantCommon Shares 27,442 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005249 · doc1.xml · nonDerivative · entry 1

Stein Kathryn Vanpelt · CIK 0001806002 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,970

F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date.

F2 · balance_after: Includes 322 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 21, 2023. The reporting person currently holds a total of 3,124 shares under the ESPP.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
GrantCommon Shares 91,680 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005253 · doc1.xml · nonDerivative · entry 2

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 805,509

F2 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:10 UTC
Tyagarajan N. V.Director · President and CEO
GrantCommon Shares 91,311 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005253 · doc1.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 713,829

F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 16:08 UTC
Mehta PiyushSenior Vice President
GrantCommon Shares 8,365 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005250 · doc1.xml · nonDerivative · entry 2

Mehta Piyush · CIK 0001408238 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,040

F3 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 16:08 UTC
Mehta PiyushSenior Vice President
GrantCommon Shares 24,349 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005250 · doc1.xml · nonDerivative · entry 1

Mehta Piyush · CIK 0001408238 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,675

F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date.

F2 · balance_after: Includes 133 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 12, 2023. The reporting person currently holds a total of 8,697 shares under the ESPP.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:07 UTC
Kalra BalkrishanSenior Vice President
GrantCommon Shares 15,791 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005248 · doc1.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,368

F2 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:07 UTC
Kalra BalkrishanSenior Vice President
GrantCommon Shares 40,249 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005248 · doc1.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,577

F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:06 UTC
Weiner Michael HalChief Financial Officer
GrantCommon Shares 17,190 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005247 · doc1.xml · nonDerivative · entry 2

Weiner Michael Hal · CIK 0001591621 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,059

F3 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:06 UTC
Weiner Michael HalChief Financial Officer
GrantCommon Shares 24,349 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005247 · doc1.xml · nonDerivative · entry 1

Weiner Michael Hal · CIK 0001591621 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,869

F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date.

F2 · balance_after: Includes 208 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on August 4, 2022. The reporting person currently holds a total of 436 shares under the ESPP.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:05 UTC
White HeatherSVP & Chief Legal Officer
GrantCommon Shares 5,615 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005246 · doc1.xml · nonDerivative · entry 2

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,845

F3 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2024, January 10, 2025 and January 10, 2026, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:05 UTC
White HeatherSVP & Chief Legal Officer
GrantCommon Shares 14,244 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-005246 · doc1.xml · nonDerivative · entry 1

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,230

F1 · shares: The reporting person was granted performance share units (PSUs) on March 20, 2022 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on January 10, 2025 subject to the reporting person's continued service through such date.

F2 · balance_after: Includes 53 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 12, 2023. The reporting person currently holds a total of 1,490 shares under the ESPP.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 20:09 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 22,280 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-23-005103 · doc1.xml · derivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 22,280 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 20:09 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 22,280 $44.40 $989,289.93
Disclosure

SEC source: 0001567619-23-005103 · doc1.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,328

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.15 to $44.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 20:09 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 22,280 $19.35 $431,118.00
Disclosure

SEC source: 0001567619-23-005103 · doc1.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:08 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,554 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-23-004663 · doc1.xml · derivative · entry 6

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,280

Underlying: Common Shares · 2,554 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:08 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 17,446 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-23-004663 · doc1.xml · derivative · entry 5

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,834

Underlying: Common Shares · 17,446 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:08 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 2,554 $47.50 $121,316.53
Disclosure

SEC source: 0001567619-23-004663 · doc1.xml · nonDerivative · entry 4

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,328

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.50 to $47.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:08 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 2,554 $19.35 $49,419.90
Disclosure

SEC source: 0001567619-23-004663 · doc1.xml · nonDerivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,882

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.